Systemic sclerosis, or scleroderma, afflicts about eight in 100,000 people in Asian populations. Read more at ...

Connective tissue growth factor, however, is constitutively overexpressed by fibroblasts present in skin fibrotic lesions, including scleroderma. The overexpression of connective tissue growth ...

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective ...

Combined data from Studies CL-QRX003-002 and CL-QRX003-003 is anticipated to provide QRX003 with the broadest possible label ...

Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patients Regulatory milestone ...

We are excited to reach this important milestone not only for our lead candidate RLS-1496 but also for the advancement of longevity science,” said Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD ...

Sponsored communities reduce timelines and increase relevance. Digital engagement allows for rapid study launches and ...

Discover early autoimmune warning signs doctors miss, from unusual fatigue to distinctive pain patterns and surprising skin ...

Unlock effective strategies for back pain treatment, including advanced techniques to support healing and reduce discomfort.

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosisNIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch ...

Women with any of three common types of autoimmune disease may face a higher rate of death linked to heart disease and stroke ...